While plenty of people rave about the weight loss results you can get from drugs like Ozempic, there’s also been a ton of ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Semaglutide compounders could be next: Novo Nordisk has asked the FDA to bar compounding pharmacies from making compounds of ...

Drugs and weight loss often go hand in hand, but the journey can feel overwhelming—especially when your wallet takes a hit.

While Ozempic has been shown to lead to weight loss as a side effect, it's not without risks. According to the Cleveland ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) prior to bariatric surgery was safe but wasn’t associated ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

A new report found people selling leftover weight loss drugs, like Ozempic or Mounjaro, on Facebook. Doctors are ...

Issues with compounded weight-loss drugs have also been investigated ... advises the pharmacies not to market their drugs as safe and effective. The lower prices of the copycat drugs also allow ...

Further, a second study presented at the meeting found that this increasingly popular class of weight loss drugs, called glucagon-like peptide-1 receptor agonists, or GLP-1 RA, appears safe and ...